Fexofenadine Synthesis via Phase-Transfer Catalysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing fexofenadine face challenges such as low yields, long chemical sequences, use of hazardous reagents, and unselective transformations, with existing processes not effectively describing suitable conditions for direct conversion of cyclopropyl aryl ketones to gamma-halo ketones for commercial production.

Innovation Solution

A process involving the direct coupling of azacyclonol with a cyclopropyl aryl ketone at elevated temperatures without solvents or with a small amount of solvent, using suitable salts as catalysts to achieve higher yields and reduce by-product formation, thereby simplifying the synthesis of fexofenadine.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods are used to convert cyclopropyl aryl ketones to gamma-halo ketones, then the reaction can proceed, but the yield is low and by-products are formed due to competing cyclisation reactions

Engineering Contradiction:
ImproveyieldVSAvoidselectivity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent changes the reaction parameters by using phase-transfer catalysts (such as tetraalkylammonium halides or crown ethers) and conducting the reaction in specific solvent systems (water-immiscible organic solvents). These parameter changes shift the reaction pathway to favor SN2 substitution over cyclisation, thereby improving both yield and selectivity of the desired gamma-halo ketone product.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces phase-transfer catalysts as intermediaries to facilitate the reaction between the cyclopropyl aryl ketone and halide source. These catalysts (quaternary ammonium salts or crown ethers) mediate the transfer of halide ions into the organic phase, enabling the substitution reaction to proceed efficiently while suppressing the competing cyclisation pathway.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If long chemical sequences with multiple steps are used, then complete conversion can be achieved, but the synthesis pathway becomes complex and time-consuming

Engineering Contradiction:
Improveconversion completenessVSAvoidsynthesis pathway complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple reaction steps into a single streamlined sequence by using the phase-transfer catalyzed substitution method. The direct conversion of cyclopropyl aryl ketones to gamma-halo ketones in one pot eliminates the need for separate cyclisation, halogenation, and purification steps, thereby reducing synthesis complexity while maintaining high conversion completeness.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent segments the synthesis pathway by identifying and optimizing the key substitution step, allowing this critical transformation to be performed independently and efficiently. This segmentation enables the complex multi-step sequence to be broken down into manageable stages, with the phase-transfer catalyzed step serving as the core transformation that replaces several conventional steps.

Inventive Principle:
Principle #1Segmentation

3Ease of operation

If hazardous reagents are used in the conventional synthesis, then the reaction can proceed under standard conditions, but environmental impact and safety concerns increase

Engineering Contradiction:
Improvereaction condition standardizationVSAvoidenvironmental impact
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent creates a safer reaction environment by using phase-transfer catalysis in water-immiscible organic solvents, which allows the reaction to proceed under milder and less hazardous conditions. This approach replaces toxic reagents with safer alternatives while maintaining reaction effectiveness, thereby reducing environmental impact and safety concerns without compromising ease of operation.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

4Speed

If intramolecular ketone alkylation is allowed to occur, then cyclisation takes place rapidly, but the desired intermolecular substitution reaction with azacyclonol is suppressed

Engineering Contradiction:
Improvecyclisation rateVSAvoidalkylation yield
Core Design Contradiction:
SpeedVSProductivity

Solution Approach 1:

The patent applies preliminary anti-action by using phase-transfer catalysts and specific solvent systems that preemptively suppress the cyclisation pathway before it can compete effectively with the desired substitution reaction. The catalyst system is designed to favor intermolecular substitution kinetics over intramolecular cyclisation, preventing the formation of unwanted cyclic by-products while maintaining rapid reaction rates.

Inventive Principle:
Principle #9Preliminary anti-action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in a shorter synthesis pathway with improved yields and reduced environmental impact, overcoming the limitations of existing methods by enabling efficient conversion of cyclopropyl aryl ketones to fexofenadine.

Implementation Method 1

The reaction is carried out at elevated temperatures without solvents or with a small amount of solvent

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 2

using suitable salts as catalysts to achieve higher yields and reduce by-product formation

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS10696633B2Process for the preparation of fexofenadine and of intermediates used therein
Publication Date: 2020.06.30 EUROAPI GERMANY GMBH
  • US10696633B2 patent drawing
  • US10696633B2 patent drawing
  • US10696633B2 patent drawing

AI summary

A new process for the preparation of fexofenadine and of related intermediates, which can be used in the preparation of fexofenadine, is provided.